The pathogenesis of experimental hormone producing ovarian tumors
Sheĭnin, P.I.
Voprosy Onkologii 16(11): 48-55
1970
ISSN/ISBN: 0507-3758 PMID: 4324427 Document Number: 23224
Document emailed within 1 workday
Related Documents
Nakagawa, S. 1970: Ectopic hormone producing tumors Rinsho Byori. Japanese Journal of Clinical Pathology 18(3): 187-194Kiss, R.; de Launoit, Y.; Danguy, A.; Paridaens, R.; Pasteels, J.L. 1989: Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors Cancer Research 49(11): 2945-2951
Kunze, M.; Büttner, H.H.; Strache, R.R.; Voss, P.; Briese, V.; Schrodt, U. 1988: CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors Zentralblatt für Gynakologie 110(16): 1006-1012
Iurkova, L.E.; Nechaeva, I.D. 1989: The antenatal period and the pathogenesis of ovarian tumors Voprosy Onkologii 35(1): 5-11
Trofimova, I.N.; Nikitin, A.I. 2004: Ovarian cancer: morphogenesis, pathogenesis, experimental induction Voprosy Onkologii 50(4): 387-398
Shevchenko, I.N.; Pinchuk, V.G. 1978: Changes in natural beta-activity and potassium concentration during the development of hormone-dependent ovarian tumors Fiziolohichnyi Zhurnal 24(2): 265-268
Volfson, N.I. 1976: On the genesis of granulosa-cell ovarian tumors. Experimental data Neoplasma 23(2): 151-160
Wei, L.H. 1989: Experimental heterotransplantation of human ovarian tumors in nude mice Zhonghua Fu Chan Ke Za Zhi 24(1): 32-34; 58-59
Li, Y.; Wei, L.-n.; Xiong, Y.-l.; Liang, X.-y. 2010: Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome Zhonghua Fu Chan Ke Za Zhi 45(8): 567-570
Ashrafi, M.; Madani, T.; Tehranian, A.S.; Malekzadeh, F. 2005: Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 91(1): 53-57
Cho, M.; Atrio, J.; Lim, A.H.; Azen, C.; Stanczyk, F.Z. 2014: Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens Contraception 90(1): 94-96
Cevrioglu, A.S.; Degirmenci, B.; Acar, M.; Yilmazer, M.; Erol, D.; Kahraman, A.; Demirel, R.; Coksuer, H. 2004: Examination of changes caused by tubal sterilization in ovarian hormone secretion and uterine and ovarian artery blood flow rates Contraception 70(6): 467-473
Ataya, K.M.; McKanna, J.A.; Weintraub, A.M.; Clark, M.R.; LeMaire, W.J. 1985: A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats Cancer Research 45(8): 3651-3656
Ataya, K.M.; Palmer, K.C.; Blacker, C.M.; Moghissi, K.S.; Mohammad, S.H. 1988: Inhibition of rat ovarian [3H]thymidine uptake by luteinizing hormone-releasing hormone agonists: a possible mechanism for preventing damage by cytotoxic agents Cancer Research 48(24 Pt 1): 7252-7256
Ohkochi, T.; Tanaka, T.; Oikawa, M.; Sakuragi, N.; Fujimoto, S.; Ichinoe, K. 1987: Effects of ovarian wedge resection (WR) and spironolactone administration on pulsatile LH release and serum steroid hormone levels in women with polycystic ovarian disease Nihon Sanka Fujinka Gakkai Zasshi 39(4): 626-632
Lemay, A.; Quesnel, G. 1982: Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist Fertility and Sterility 38(3): 376-379
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Costa, M.J.; Morris, R.; DeRose, P.B.; Cohen, C. 1993: Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors Archives of Pathology and Laboratory Medicine 117(8): 802-808
Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Reyes, F.I.; Winter, J.S.; Faiman, C. 1977: Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels American Journal of Obstetrics and Gynecology 129(5): 557-564